Dr Adi Hoess
Chief Executive Officer
Dr Adi Hoess brings over two decades of experience in biotechnology.
Dr Adi Hoess brings over two decades of experience in biotechnology.
Steven Altschuler brings nearly 25 years of experience building and leading world-class, integrated, translational, value-based health care systems and transformational biotechnology companies.
Technology inventor and Professor of Molecular Bionics at IBEC in Barcelona
David is an Oxford-based life sciences angel investor.
Owen is a Partner at 4BIO Capital.
Member of the BGF Investment Team in Cambridge and the South East
UCB Ventures Principal